1-4 of 4
Linda Brand
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of a Novel Reduced Toxicity Preparative Regimen for Hematopoietic Cell Allografting Combining Pentostatin (Nipent) and Targeted Doses of Intravenous Busulfan (Busulfex) with or without Rituximab (PB±R) Using a Novel Principle of CD4-Guided Immune Suppression

Mohamed A Kharfan-Dabaja, MD, Claudio Anasetti, MD, Nathalie Luis, B.S., Linda Brand, R.N., Janelle Perkins, PharmD, Hugo F. Fernandez, MD, Jose Leonel Ochoa-Bayona, M.D., Taiga Nishihori, MD, Lia E Perez, MD, Ernesto Ayala, MD, Javier Pinilla-Ibarz, MD, PhD, Lubomir Sokol, MD, PhD, Joseph Pidala, MD, MS, Frederick L Locke, MD, Eduardo M. Sotomayor, Teresa Field, MD, PhD, Marcie Tomblyn, MD, MS
Journal: Blood
Blood (2011) 118 (21): 3022.
https://doi.org/10.1182/blood.V118.21.3022.3022
Published: 2011
Journal Articles

Hypoalbuminemia (< 3.0 g/dl) and Poor Karnofsky Performance Score (<80) at Day 90 Following Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT) Are Independent Predictors of Worse Non-Relapse Survival (NRS) and Overall Survival (OS): A Multivariable Analysis Approach of Various Clinical, Laboratory and Pharmacologic Parameters

Mohamed A Kharfan-Dabaja, MD, Julio C. Chavez, Eduardo Ivan Fernandez-Vertiz, Daohai Yu, Weiwei Zhu, Janelle Perkins, Teresa Field, Ernesto Ayala, Hugo F. Fernandez, Melissa Alsina, Lia Perez, Jyotishankar Raychaudhuri, J. Leonel Ochoa-Bayona, Linda Brand, Dan Sullivan, Claudio Anasetti
Journal: Blood
Blood (2008) 112 (11): 4329.
https://doi.org/10.1182/blood.V112.11.4329.4329
Published: 2008
Journal Articles

Administration of Rituximab 375 Mg/m2 on Days +1 and +8 after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT) Regimens for Patients with Advanced CD20+ Lymphoid Malignancies

Mohamed A Kharfan-Dabaja, MD, Cheryl Tate, Janelle Perkins, Teresa Field, Hugo F. Fernandez, Melissa Alsina, Ernesto Ayala, Jyotishankar Raychaudhuri, Lia Perez, J. Leonel Ochoa-Bayona, Linda Brand, Javier Pinilla-Ibarz, Eduardo Sotomayor, Dan Sullivan, Claudio Anasetti
Journal: Blood
Blood (2008) 112 (11): 4323.
https://doi.org/10.1182/blood.V112.11.4323.4323
Published: 2008
Journal Articles

Administration of Rituximab Is Feasible and Does Not Affect Engraftment of Allograft Recipients with Advanced CD20+ Malignancies.

Mohamed A. Kharfan-Dabaja, MD, Cheryl Tate, PharmD, Janelle Perkins, PhD, Hugo F. Fernandez, MD, Teresa Field, MD, Ernesto Ayala, MD, Lia Perez, MD, Jyotishankar Raychaudhuri, MD, Melissa Alsina, MD, Dan Sullivan, MD, Linda Brand, RN, William Poling, PhD, Claudio Anasetti, MD
Journal: Blood
Blood (2007) 110 (11): 3016.
https://doi.org/10.1182/blood.V110.11.3016.3016
Published: 2007